penis enlargement

DHT and Prostate Health

May 28, 2010

DHT and Prostate HealthDHT often gets a bad rap. It’s blamed for hair loss in men and women, as well as prostate growth. However, scientists are challenging some of these assumptions with research into DHT and benign prostate hypertrophy (BPH.) Some studies have suggested that higher estrogen levels are a cause of BPH. This has some researchers thinking that DHT–which cannot be converted to estrogen–could actually be used to treat BPH, and have filed a patent on their research.

Dihydrotestosterone for use in androgenotherapy
United States Patent 5648350

The present invention is directed to the administration of dihydrotestosterone (DHT) for preventing prostate cancer in male patients more than 50 years old and of reducing levels of plasma-borne sex hormone binding globulins (SHBG) in male patients having elevated levels thereof.

A short-term study with an aromatase inhibitor in men suffering from BPH has shown a mean reduction of 26% of the prostate volume, which reinforces the hypothesis of the responsibility, also for men, of certain estrogens. Not only does the activity of aromarase tend to increase with age, but experience suggests a slight tendency toward less sensitivity of the prostate cells to DHT with age, and on the contrary, toward a greater sensitivity to estradiol.

Read the full patent application here.

The research uses a 2.5% DHT hydroalcoholic gel (Andractim.)